SCHEMBL21490455

SCHEMBL21490455

O=C(CN1CCCCC1)Oc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ KMT2A Q03164 7/20 0.54
▸ MEN1 O00255 5/20 0.54
▸ GLA P06280 1/20 0.54
▸ GAA P10253 1/20 0.52
▸ HPGD P15428 1/20 0.51
▸ KDM4E B2RXH2 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ HRH3 Q9Y5N1 1/20 0.49
▸ LMNA P02545 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ RAD52 P43351 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28820059 0.98 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2KMT2AMEN1GLA
Hydrochloric Acid SCHEMBL28283970 0.97 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2KMT2AMEN1GLA
SCHEMBL13150723 0.86 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2KMT2AMEN1GLA
SCHEMBL24177783 0.83 KMT2A (0.58) ALDH1A1SMN1; SMN2KMT2AMEN1GAA
SCHEMBL21590285 0.83 GAA (0.57) ALDH1A1SMN1; SMN2KMT2AMEN1GAA
SCHEMBL29118248 0.83 LMNA (0.46) ALDH1A1SMN1; SMN2KMT2AMEN1KDM4E
Hydrochloric Acid SCHEMBL27859860 0.82 EGFR (0.49) ALDH1A1SMN1; SMN2KMT2AMEN1GLA
SCHEMBL12551243 0.82 FAAH (0.45) ALDH1A1SMN1; SMN2KMT2AGAALMNA
Bromide SCHEMBL15967768 0.81 EGFR (0.45) ALDH1A1SMN1; SMN2KMT2AMEN1GAA
SCHEMBL13150837 0.80 KCNA5 (0.65) ALDH1A1SMN1; SMN2KMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10834891-B2 Pre-frontal cortex processing disorder speech gait and limb impairments treatment GILROSE PHARMACEUTICALS, LLC (US) 2020-11-17 — — US disclosed
US-20190320611-A1 PRE-FRONTAL CORTEX PROCESSING DISORDER SPEECH GAIT AND LIMB IMPAIRMENTS TREATMENT GILROSE PHARMACEUTICALS, LLC (US) 2019-10-24 — — US disclosed
CN-109689527-A Transdermal delivery system and its method comprising methylphenidate or its salt 泰合生技药品股份有限公司 2019-04-26 — — CN disclosed
CN-101594999-B Method of producing an information carrier AGFA GEVAERT 2011-10-12 — — CN disclosed
CN-101594999-A The method of manufacturing information carrier AGFA GEVAERT (BE) 2009-12-02 — — CN disclosed
Send feedback